FINWIRES · TerminalLIVE
FINWIRES

Jiangxi Rimag to Acquire Sun Seeds, Wingon Medical in HK$353 Million Deal

作者

-- Jiangxi Rimag (HKG:2522) agreed to acquire 100% equity interests in Hong Kong Sun Seeds Management and Wingon Medical Technology, according to a Monday Hong Kong bourse filing.

The consideration comprises HK$185.4 million for Hong Kong Sun Seeds Management and HK$168 million for Wingon Medical Technology, to be settled through the issue of consideration shares and the transfer of treasury shares.

The two target companies primarily hold equity interests in Medical Image Insights.

Upon completion, Jiangxi Rimag's effective interest in Medical Image Insights will increase to about 25.4% as the stakes held through the targets become fully attributable to the group.

The company will issue 49.4 million new shares and transfer 5.7 million treasury shares to the sellers, with the consideration price set at HK$6.405 per share.

相关文章

Research

Rothschild & Co Redburn 将 Rollins 的评级从“中性”上调至“买入”，并将目标价从 51.90 美元调整至 66 美元。

根据FactSet调查的分析师报告，Rollins (ROL) 的平均评级为“增持”，平均目标价为65.20美元。 （报道北美、亚洲和欧洲主要银行及研究机构的股票、商品和经济研究。研究机构可通过以下链接联系我们：https://www..com/contact-us）

$ROL
Research

Arete Research 将 Fortinet 的评级从“卖出”上调至“买入”，并将目标价从 83 美元上调至 104 美元。

根据FactSet调查的分析师数据，Fortinet (FTNT) 的平均评级为“持有”，平均目标价为88.45美元。 （报道北美、亚洲和欧洲主要银行及研究机构的股票、商品和经济研究。研究机构可通过以下链接联系我们：https://www..com/contact-us）

$FTNT
Research

法国巴黎银行将GE Vernova的评级从“跑赢大盘”下调至“中性”，并将目标价从765美元上调至1190美元。

根据FactSet调查的分析师报告，GE Vernova (GEV) 的平均评级为“增持”，平均目标价为1179.31美元。 （报道北美、亚洲和欧洲主要银行及研究机构的股票、商品和经济研究。研究机构可通过以下链接联系我们：https://www..com/contact-us）

$GEV